The use of enoxaparin as bridge to therapeutic INR after LVAD implantation.
Zubair ShahIoannis MastorisPrakash AcharyaAniket S RaliMoghni MohammedFarhad SamiSagar RankaSavahanna WagnerGiorgio ZanottiChristopher T SalernoNicholas A HaglundAndrew J SauerAshwin K RavichandranTravis AbichtPublished in: Journal of cardiothoracic surgery (2020)
LMWH in the immediate and early postoperative period after LVAD implantation appears to be a concurrently safe and efficacious option allowing earlier postoperative discharge and avoidance of recurrent hospitalizations due to sub-therapeutic INR.